Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065 (S.W., P.C.A., H.H.); Department of Radiology, NYU Langone Health, 660 1st Avenue, New York, NY, 10016 (S.W., H.A.V.).
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065 (S.W., P.C.A., H.H.).
Acad Radiol. 2024 Apr;31(4):1388-1397. doi: 10.1016/j.acra.2023.08.005. Epub 2023 Sep 1.
This study aimed to evaluate whether implementing structured reporting based on Ovarian-Adnexal Reporting and Data System (O-RADS) magnetic resonance imaging (MRI) in women with sonographically indeterminate adnexal masses improves communication between radiologists, referrers, and patients/caregivers and enhances diagnostic performance for determining adnexal malignancy.
We retrospectively analyzed prospectively issued MRI reports in 2019-2022 performed for characterizing adnexal masses before and after implementing O-RADS MRI; 56 patients/caregivers and nine gynecologic oncologists ("referrers") were surveyed about report interpretability/clarity/satisfaction; responses for pre- and post-implementation reports were compared using Fisher's exact and Chi-squared tests. Diagnostic performance was assessed using receiver operating characteristic curves.
A total of 123 reports from before and 119 reports from after O-RADS MRI implementation were included. Survey response rates were 35.7% (20/56) for patients/caregivers and 66.7% (6/9) for referrers. For patients/caregivers, O-RADS MRI reports were clearer (p < 0.001) and more satisfactory (p < 0.001) than unstructured reports, but interpretability did not differ significantly (p = 0.14), as 28.0% (28/100) of postimplementation and 38.0% (38/100) of preimplementation reports were considered difficult to interpret. For referrers, O-RADS MRI reports were clearer, more satisfactory, and easier to interpret (p < 0.001); only 1.3% (1/77) were considered difficult to interpret. For differentiating benign from malignant adnexal lesions, O-RADS MRI showed area under the curve of 0.92 (95% confidence interval [CI], 0.85-0.99), sensitivity of 0.81 (95% CI, 0.58-0.95), and specificity of 0.91 (95% CI, 0.83-0.96). Diagnostic performance of reports before implementation could not be calculated due to many different phrases used to describe the likelihood of malignancy.
Implementing standardized structured reporting using O-RADS MRI for characterizing adnexal masses improved clarity and satisfaction for patients/caregivers and referrers. Interpretability improved for referrers but remained limited for patients/caregivers.
本研究旨在评估在经超声检查表现为附件区不明性质肿块的患者中实施基于卵巢-附件报告和数据系统(O-RADS)磁共振成像(MRI)的结构化报告是否能够改善放射科医师、转诊医师和患者/照护者之间的沟通,并提高确定附件区恶性肿瘤的诊断性能。
我们回顾性分析了 2019 年至 2022 年期间为明确附件区肿块性质而前瞻性实施的 O-RADS MRI 前后的 MRI 报告;对 56 名患者/照护者和 9 名妇科肿瘤医生(“转诊医生”)进行了报告解读的可理解性/清晰度/满意度调查;使用 Fisher 确切检验和卡方检验比较实施前后报告的结果。使用受试者工作特征曲线评估诊断性能。
共纳入了 123 份 O-RADS MRI 实施前的报告和 119 份 O-RADS MRI 实施后的报告。患者/照护者的调查应答率为 35.7%(20/56),转诊医生的应答率为 66.7%(6/9)。对于患者/照护者,O-RADS MRI 报告更清晰(p<0.001),更令人满意(p<0.001),但可理解性无显著差异(p=0.14),因为实施后 28.0%(28/100)的报告和实施前 38.0%(38/100)的报告被认为难以理解。对于转诊医生,O-RADS MRI 报告更清晰、更令人满意、更容易理解(p<0.001);仅 1.3%(1/77)被认为难以理解。在区分良性和恶性附件病变方面,O-RADS MRI 的曲线下面积为 0.92(95%置信区间[CI],0.85-0.99),敏感性为 0.81(95%CI,0.58-0.95),特异性为 0.91(95%CI,0.83-0.96)。由于使用了许多不同的短语来描述恶性肿瘤的可能性,因此无法计算实施前报告的诊断性能。
在为明确附件区肿块性质而实施的 O-RADS MRI 中使用标准化的结构化报告提高了患者/照护者和转诊医生的清晰度和满意度。转诊医生的可理解性提高了,但患者/照护者的可理解性仍然有限。